Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology Insulin Pump Management Task Force

George Grunberger, MD, FACP, FACE (Chair); Jill M. Abelseth, MD, FACE; Timothy S. Bailey, MD, FACP, FACE, ECNU; Bruce W. Bode, MD, FACE; Yehuda Handelsman, MD, FACP, FACE, FNLA; Richard Hellman, MD, FACP, FACE; Lois Jovanovič, MD, MACE; Wendy S. Lane, MD; Philip Raskin, MD, FACE; William V. Tamborlane, MD; Caitlin Rothermel, MA (Medical writer); Chair, George Grunberger, MD, FACP, FACE; Jill M. Abelseth, MD, FACE; Timothy S. Bailey, MD, FACP, FACE, ECNU; Bruce W. Bode, MD, FACE; Yehuda Handelsman, MD, FACP, FACE, FNLA; Richard Hellman, MD, FACP, FACE; Lois Jovanovič, MD, MACE; Wendy S. Lane, MD; Philip Raskin, MD, FACE; William V. Tamborlane, MD; Medical Writer, Caitlin Rothermel, MA

Disclosures

Endocr Pract. 2014;20(5):463-489. 

In This Article

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Guidelines are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

processing....